HRT breast cancer link in doubt
Your support helps us to tell the story
From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.
At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.
The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.
Your support makes all the difference.Controversy over the link between hormone replacement therapy and breast cancer has been reignited after scientists cast doubt on the report which first established the connection.
The "Million Women Study" of 2003 concluded that taking HRT doubled a woman's risk of developing breast cancer. This risk has been underlined by further findings from the study, funded by Cancer Research UK.
But scientists writing in the Journal of Family Planning and Reproductive Health cast doubt on the conclusions after identifying flaws which they claimed would have skewed the findings. "If the evidence was unreliable, the only effect of its massive size would have been to confer spurious statistical authority to doubtful findings," critics said.
Join our commenting forum
Join thought-provoking conversations, follow other Independent readers and see their replies
Comments